NECOX
Price
$21.28
Change
-$0.10 (-0.47%)
Updated
Jun 18 closing price
Net Assets
913.45M
RMFEX
Price
$62.81
Change
+$0.30 (+0.48%)
Updated
Jun 18 closing price
Net Assets
116.64B
Interact to see
Advertisement

NECOX vs RMFEX

NECOX vs RMFEX Comparison Chart in %
View a ticker or compare two or three
VS
NECOX vs. RMFEX commentary
Jun 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NECOX is a Hold and RMFEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 117B vs. NECOX (913M). RMFEX pays higher dividends than NECOX: RMFEX (1.45) vs NECOX (0.33). NECOX was incepted earlier than RMFEX: NECOX (31 years) vs RMFEX (24 years). NECOX (1.81) is less costly to investors than RMFEX (0.62). NECOX is a more actively managed with annual turnover of: 53.00 vs. RMFEX (30.00). RMFEX has a lower initial minimum investment than NECOX: RMFEX (250) vs NECOX (2500). RMFEX annual gain was more profitable for investors over the last year : 10.20 vs. NECOX (-3.25). RMFEX return over 5 years is better than : 39.81 vs. NECOX (-6.92).
NECOXRMFEXNECOX / RMFEX
Total Expense Ratio1.780.62287%
Annual Report Gross Expense Ratio1.810.62292%
Fund Existence31 years24 years-
Gain YTD-7.3666.326-116%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets913M117B1%
Annual Yield % from dividends0.331.4523%
Returns for 1 year-3.2510.20-32%
Returns for 3 years10.8433.7432%
Returns for 5 years-6.9239.81-17%
Returns for 10 years33.63101.9433%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IAFMX21.29-0.18
-0.84%
F/m Investments Large Cap Focused Inv
CDVZX20.48-0.20
-0.96%
Columbia Intrinsic Value Institutional
VDSCX21.15-0.21
-0.98%
Victory Diversified Stock C
JRASX89.72-1.04
-1.15%
Janus Henderson Research S
GSUTX66.33-0.85
-1.27%
Goldman Sachs US Equity Insights Inv